期刊文献+

新疆某地艾滋病防治卫生经济学评价 被引量:2

Evaluation on the Health Economics of HIV Prevention and Control in an Area of Xinjiang
原文传递
导出
摘要 目的:对新疆某地艾滋病综合防治开展卫生经济学评价,为政府合理配置卫生资源提供科学的依据。方法:收集目标地区2011—2015年艾滋病防治经费来源及使用情况结合数学模型预测结果开展成本效果及成本效益分析。结果:当地每减少一例新发感染所需成本约为5.7~6.1万元,成本效果数据呈逐年下降趋势,由2011年的8.9万元降至2015年的4.6万元;当地效益成本比为3.04~3.27,呈逐年上升趋势,由2011年的2.09上升至2015年的4.02;5年总收益高达6.79亿元,其中公共收益4.99亿元,个人收益1.80亿元。结论:艾滋病综合防治措施具有显著的成本效果和成本效益,建议政府在卫生资源分配时给予适当倾斜并制定资金的长期规划。 Objective: To provide suggestions for the rational allocation of health resources through the health economics evaluation of HIV prevention and control in all area of Xinjiang. Methods: The implementation cost of HIV prevention strategies from 2011 to 2015 was collected. Health economics evaluation was conducted based on the finds of cost analysis and model prediction. Results: It needed about 57 000--61 000 yuan to reduce a new infection and the cost reduced from 890 000 in 2011 to 460 000 in 2015. The benefit-cost ratio was 3.04-3.27, which had yearly increasing trend. The ratio increased from 2.09 in 2011 to 4.02 in 2015. It was totally produced about 679 million yuan which included 499 million yuan in public and 180 million yuan in personality. Conclusion: HIV prevention and control had high cost-effective and cost-benefit. It was recommended that the government should give a priorily during the allocation of health resources and develop a tong-term funding plan.
作者 倪明健 陈学玲 胡晓远 马媛媛 NI Ming-jian;CHEN Xue-ling;HU Xiao-yuan(Xinjiang Center for Disease Prevention and Control,Urumqi,830011,China)
出处 《中国卫生经济》 北大核心 2018年第8期64-66,共3页 Chinese Health Economics
基金 "艾滋病和病毒性肝炎等重大传染病防治"科技重大专项(2013ZX10004907) 新疆维吾尔自治区科技支撑计划项目(201433107)
关键词 获得性免疫缺陷综合征 综合防治 成本-效果 成本-效益 新疆 HIV comprehensive prevention and control cost-effective cost-benefit Xinjiang
  • 相关文献

参考文献5

二级参考文献20

  • 1陈宁姗.成本-效果分析在艾滋病预防干预措施经济学评价中的应用[J].中国初级卫生保健,2004,18(11):30-32. 被引量:15
  • 2白玥,王世勇,张毓辉.中央艾滋病防治经费投入的公平性分析[J].中国艾滋病性病,2006,12(2):113-116. 被引量:11
  • 3郭金玲,王宇明,王仲阳,郭大成,梁淑英,田庆丰,施学忠,李立,胡晓燕,张亮.农村艾滋病高发地区社会疾病经济负担分析[J].中国公共卫生,2006,22(8):998-1000. 被引量:19
  • 4[4]Digiovine B,Chenoweth C,Watts C,et al.The attributable mortality and costs of primary nosocomial bloodstream infectious in the intensive care unit[J].Am J Respir Crit Care Med,1999,160(3):976
  • 5卫生部办公厅.2004年艾滋病防治项目管理方案[R].北京:卫生部办公厅,2004.
  • 6卫生部办公厅.2009年艾滋病防治项目管理方案[R].北京:卫生部办公厅,2009.
  • 7中华人民共和国国务院.国务院关于进一步加强艾滋病防治工作的通知[EB/OL].(2011-02-16)[2015-01-29].http://www.gov.cn/zwgk/2011-02/16/content一1804536.htm.
  • 8Alistar SS,Owens DK,Brandeau ML. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine[J]. PLoS Med,2011,8(3): e1000423.
  • 9Antiretroviral Therapy Cohort Collaboration. Life expectancy ofindividuals on combination antiretroviral therapy in high-incomecountries : a collaborative analysis of 14 cohort studies [j]. Lancet,2008,26:372(9635):293-299.
  • 10中国疾控疾病预防控制中心性病艾滋病预防控制中心.国家免费艾滋病抗病毒治疗药物手册[M]. 3版.北京:人民卫生出版社,2012.

共引文献33

同被引文献25

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部